Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Denemarken
  4. Nasdaq Copenhagen
  5. Zealand Pharma A/S
  6. Nieuws
  7. Persberichten
    ZEAL   DK0060257814

ZEALAND PHARMA A/S

(ZEAL)
uitgestelde koers. Vertraagde tijd Nasdaq Copenhagen - 20/01 16:59:37
138 DKK   --.--%
14/01Europese ADR's bewegen hoger in de vrijdaghandel
MT
2021Europese ADR's bewegen hoger in maandaghandel
MT
2021Europese ADR's bewegen hoger in donderdaghandel
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť ZEALAND PHARMA A/S
20/01Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide ..
AQ
19/01ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, January 2022
AQ
12/01Scandion Oncology enhances its external communication
AQ
03/01Zealand Pharma to†Participate in†H.C. Wainwright BIOCONNECT 2022 Conference
AQ
2021ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, 2021
AQ
2021Zealand Pharma Announces Enrollment of Last Patient Needed for Interim Analysis of EASE..
GL
2021ZEALAND PHARMA A/S : Announces Seven-Year, $200 Million Financing Agreement with Oberland ..
PU
2021Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Cap..
GL
2021Zealand Pharma increases its share capital as a consequence of exercise of employee war..
AQ
2021ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, 2021
AQ
2021ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2021
AQ
2021ZEALAND PHARMA A/S : announces successful outcome of Phase 1b clinical trial with GLP1-GLP..
PU
2021Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 d..
GL
2021ZEALAND PHARMA A/S : Company announcement – No. 69/ 2021 Company announcement &ndash..
PU
2021Zealand Pharma increases its share capital as a consequence of exercise of employee war..
AQ
2021Zealand Pharma to†Participate in†Jefferies London Healthcare Conference
AQ
2021Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides U..
PU
2021Read Report
PU
2021Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides U..
GL
2021Zealand Pharma and DEKA Research & Development Corp. Announce Collaboration Agreement t..
PU
2021Zealand Pharma and DEKA Research & Development Corp. Announce Collaboration Agreement t..
AQ
2021Zealand Pharma Announces First Subject Dosed in Phase 1 Trial of Amylin Analogue ZP8396..
AQ
2021Zealand Pharma Hosts Conference Call on November 11 at 4 pm CET (10 am ET) to Present T..
GL
2021Zealand Pharma Announces Presentation of Preclinical Data on Amylin Analogue, ZP8396, a..
AQ
2021ZEALAND PHARMA A/S : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION (Form 6-..
PU
2021ZEALAND PHARMA A/S : Transactions in Zealand Pharma shares†and/or related securities by pe..
AQ
2021ZEALAND PHARMA A/S : increases its share capital as a consequence of exercise of employee ..
AQ
2021Zealand Pharma Presents Data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependen..
GL
2021ZEALAND PHARMA A/S : Transactions in Zealand Pharma shares†and/or related securities by pe..
AQ
2021ZEALAND PHARMA A/S : New Employee Elected Director to the board of Zealand Pharma A/S (For..
PU
2021ZEALAND PHARMA A/S : to Participate in Morgan Stanley 19th Annual Global Healthcare Confer..
AQ
2021ZEALAND PHARMA A/S : Transactions in Zealand Pharma shares and/or related securities by pe..
AQ
2021ZEALAND PHARMA A/S : New Employee Elected Director to the board of Zealand Pharma A/S
AQ
2021ZEALAND PHARMA A/S : to Participate in Goldman Sachs 11th Annual Biotech Symposium
AQ
2021ZEALAND PHARMA A/S : Company announcement – No. 53 / 2021 (Form 6-K)
PU
2021ZEALAND PHARMA A/S : increases its share capital as a consequence of exercise of employee ..
AQ
2021Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Gle..
GL
2021ZEALAND PHARMA A/S : Employee Elected Director to step down from the board of Zealand Phar..
AQ
2021ZEALAND PHARMA A/S : First Half 2021 Report
PU
2021Zealand Pharma Launches ZEGALOGUEģ (dasiglucagon) Injection and Advances Pipeline Progr..
GL
2021ZEALAND PHARMA A/S : Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present S..
AQ
2021ZEALAND PHARMA A/S : Final Transactions Under Share Repurchase Program (Form 6-K)
PU
2021ZEALAND PHARMA A/S : – Final Transactions Under Share Repurchase Program
AQ
2021ZEALAND PHARMA A/S : Transaction Under Share Repurchase Program (Form 6-K)
PU
2021Zealand Pharma A/S – Transaction Under Share Repurchase Program
GL
2021ZEALAND PHARMA A/S : – Transaction Under Share Repurchase Program
AQ
2021Zealand pharma a/s - transactions under share repurchase program
GL
2021ZEALAND PHARMA A/S : SHARE BUY-BACK PROGRAM UNDER SAFE HARBOUR TO AQUIRE DANISH COMMON STO..
PU
2021Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal R..
GL
2021ZEALAND PHARMA A/S : to Present Data on Glepaglutide at the 17th Congress of the Intestina..
PU
2021Zealand Pharma A/S - Share Buy-Back Program Under Safe Harbour to Aquire Danish Common ..
GL
2021ZEALAND PHARMA A/S : introduces ConnectedCareTM patient support program to facilitate acce..
PU
2021Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUEģ (dasiglucagon) inje..
GL
2021Zealand Pharma to Participate in LifeSci Nordic Biotech Summit
GL
2021Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual Ame..
GL
2021Transactions in Zealand Pharma shares and/or related securities by persons discharging ..
GL
2021ZEALAND PHARMA A/S : increases its share capital as a consequence of exercise of employee ..
AQ
2021ZEALAND PHARMA A/S : Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Design..
PU
2021Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
GL
2021Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investig..
GL
2021ZEALAND PHARMA A/S : Transactions in Zealand Pharma shares and/or related securities by pe..
AQ
2021Transactions in Zealand Pharma shares and/or related securities by persons discharging ..
GL
2021ZEALAND PHARMA A/S : Company announcement – No. 33 / 2021 (Form 6-K)
PU
2021ZEALAND PHARMA A/S : launches long-term incentive program for Zealand's US based Corporate..
AQ
2021Zealand Pharma to participate in Jefferies Virtual Healthcare Conference
GL
2021Zealand Pharma increases its share capital as a consequence of exercise of employee war..
GL
2021ZEALAND PHARMA A/S : Transactions in Zealand Pharma shares and/or related securities by pe..
PU
2021ZEALAND PHARMA A/S : receives first FDA approval and prepares for launch of Zegalogueģ (da..
PU
2021ZEALAND PHARMA A/S : Company announcement – No. 28/ 2021 (Form 6-K)
PU
2021ZEALAND PHARMA A/S : Transactions in Zealand Pharma shares and/or related securities by pe..
AQ
2021ZEALAND PHARMA A/S : first quarter 2021 Presentation
PU
2021Zealand Pharma receives first FDA approval and prepares for launch of Zegalogueģ†(dasig..
GL
2021ZEALAND PHARMA A/S : launches long-term incentive program for Zealand's Executive Manageme..
AQ
2021Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10 am ET) to Present First ..
GL
2021Transactions in Zealand Pharma shares and/or related securities by persons discharging ..
GL
1  2  3  4  5Volgende
Volgende evenement op ZEALAND PHARMA A/S
10/03/22